Beata Matyjaszek-Matuszek
Overview
Explore the profile of Beata Matyjaszek-Matuszek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Zwolak A, Swirska J, Tywanek E, Dudzinska M, Tarach J, Matyjaszek-Matuszek B
Endokrynol Pol
. 2020 Aug;
71(3):256-259.
PMID: 32797472
Von Hippel-Lindau disease is a highly penetrant autosomal genetic disorder caused by a germline mutation in the tumour suppressor gene, manifesting with the formation of various tumours, including neuroendocrine tumours...
22.
Polak A, Grywalska E, Klatka J, Rolinski J, Matyjaszek-Matuszek B, Klatka M
Int J Mol Sci
. 2019 Sep;
20(19).
PMID: 31554206
Graves' disease (GD) is an autoimmune disease that affects the thyroid. The development of autoimmunity is associated with innate immune responses where the prominent role plays Toll-like receptors (TLRs). The...
23.
Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Ludian J, Kiszczak-Bochynska E, Smolen A, et al.
Int J Mol Sci
. 2019 Jun;
20(13).
PMID: 31252621
Graves' disease (GD) it the most common chronic organ-specific thyroid disorder without a fully recognized etiology. The pathogenesis of the disease accounts for an interaction between genetic, environmental, and immunological...
24.
Frias J, Wynne A, Matyjaszek-Matuszek B, Bartaskova D, Cox D, Woodward B, et al.
Diabetes Obes Metab
. 2019 May;
21(9):2048-2057.
PMID: 31050143
Aims: Dulaglutide, a once weekly GLP-1 receptor agonist, is approved at two doses (1.5 and 0.75 mg) for treatment of type 2 diabetes (T2D). Two higher doses of dulaglutide (3.0...
25.
Rudzki G, Lenart-Lipinska M, Smolen A, Chrapko B, Matyjaszek-Matuszek B
Endokrynol Pol
. 2018 Nov;
70(2):157-164.
PMID: 30480751
Introduction: Subclinical hyperthyroidism (SCH), also known as mildly symptomatic hyperthyroidism, has recently been diagnosed more frequently. One of the main endogenous causes of this disorder is autonomously functioning thyroid nodule...
26.
Swirska J, Zwolak A, Dudzinska M, Matyjaszek-Matuszek B, Paszkowski T
Ginekol Pol
. 2018 Oct;
89(9):522-527.
PMID: 30318581
The incidence of gestational diabetes mellitus (GDM) increases globally, including Poland. Considering serious consequences of gestational diabetes for both mother and fetus, screening for this disorder is an obligatory element...
27.
Matyjaszek-Matuszek B, Obel E, Lewicki M, Kowalczyk-Boltuc J, Smolen A
Ann Agric Environ Med
. 2018 Sep;
25(3):559-561.
PMID: 30260174
Introduction: Acromegaly is an endocrine disorder caused predominantly by pituitary adenoma leading to autonomic oversecretion of growth hormone and secondary elevation of insulin-like growth factor 1 (IGF-1). Consequently, there are...
28.
Matyjaszek-Matuszek B, Szafraniec A, Porada D
Endokrynol Pol
. 2018 Sep;
69(4).
PMID: 30209803
Obesity, which affects about 13% of the world population, results in significant deterioration of health and serious clinical, mainly meta-bolic and cardiovascular complications. Although the basis of therapeutic treatment is...
29.
Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Smolen A, Pyzik D, Rolinski J
Mol Cell Endocrinol
. 2017 Mar;
448:28-33.
PMID: 28284988
PD-1 maintains tolerance and inhibits autoimmune responses. Graves' disease (GD) is one of the most frequent autoimmune diseases of unclear etiology. The aim of this study was to evaluate the...
30.
Swirska J, Czuczwar P, Zwolak A, Matyjaszek-Matuszek B
Ginekol Pol
. 2016 Jun;
87(3):194-9.
PMID: 27306128
Objectives: The aim of the study was to estimate whether diabetes was an independent risk factor for perioperative complications in patients undergoing gynecologic surgery. Material And Methods: The study population...